India at a Turning Point: Legal Reform, Global Investment and the Next Phase of Cross-Border Business

JURISDICTION OVERVIEW

• GDP growth of 6.6–7.4% forecast for FY 2025–26, driven by domestic consumption, public capex at 3.4% of GDP, and RBI rate cuts totalling 125 basis points in FY25; India retains its position as the world's fastest-growing major economy.
• Government posture is decidedly pro-investment: insurance sector opened to 100% FDI, SEBI’s SWAGAT-FI single-window framework operationalises June 2026, and two landmark FTAs (India–UK, July 2025; India–EU, January 2026) are in the ratification pipeline.
• The DPDP Rules 2025, notified November 2025, introduce a phased data protection architecture — Phase 1 enforcement active now, full substantive compliance due May 2027 — reshaping data governance across all sectors with cross-border exposure.
• Forward signal (H2 2026): India chairs BRICS 2026 and the India–Canada CEPA negotiations formally launched March 2026; trade diversification continues to reduce US-tariff dependency.

KEY LEGAL DEVELOPMENTS (LAST 6–12 MONTHS)

DPDP Rules 2025 — MeitY Notification (13 November 2025)

• MeitY notified the Digital Personal Data Protection Rules 2025, operationalising the DPDP Act 2023 in three phases; the Data Protection Board of India (DPBI) is now active with full investigative and penalty powers (up to INR 250 crore per breach).
• Phase 2 (November 2026) requires Consent Manager registration; Phase 3 (May 2027) activates all substantive obligations including notice, consent, data principal rights, and mandatory breach notification.
• Immediate action required: legacy data collected pre-notification must receive retrospective consent notices; multinationals handling Indian user data must begin data-mapping and governance redesign now.

100% FDI in Insurance — Finance Ministry Gazette (2025)

• Insurance FDI cap raised from 74% to 100%; revised management rules permit foreign-controlled boards provided at least one of CEO, MD, or Chairperson is a resident Indian citizen.
• Opens insurance sector structuring opportunities for foreign strategic investors; prior approval route remains for sensitive acquisitions; board composition and localisation obligations require fresh structuring advice.

India–EU Free Trade Agreement — Concluded 27 January 2026

• India and EU concluded negotiations covering 20 chapters including goods, services, digital trade, IP, investment protection, and dispute settlement; provisional text published February 2026 pending legal scrub and formal signing.
• Preferential access for 99%+ of India’s exports by trade value; EU ratification process expected to conclude early 2027 when FTA enters into force; Indian IP commitments in the agreement are a watch point for patent and trademark counsel.

FEMA (Borrowing & Lending) First Amendment Regulations 2026 — RBI (February 2026)

• RBI amended the ECB framework: broadened eligible borrower categories, aligned pricing with international standards, and strengthened end-use compliance; effective 16 February 2026.
• Foreign lenders and PE funds structuring Indian debt instruments must review ECB documentation and pricing benchmarks for compliance with the revised framework.

PRACTICE-SPECIFIC INSIGHTS

Cross-Border Corporate / FDI

• DPIIT April 2025 clarification — bonus share issuances to non-resident shareholders in FDI-restricted sectors are permissible without triggering automatic route violations, provided ownership percentages remain unchanged; retrospective validation removes legacy enforcement risk for affected companies.
• SEBI SWAGAT-FI, operative from June 2026, creates a fast-track compliance corridor for government-linked investors, sovereign wealth funds, and large public retail funds; practitioners advising sovereign and quasi-sovereign clients should initiate eligibility assessments immediately.
• FPI threshold clarification: the 49% aggregate cap for FPI holdings has been removed; aggregate cap now equals the applicable sectoral FDI cap, improving headroom for institutional investors building strategic positions.

Minority Shareholder Protection / NCLT

• Pannalal Bhansali v. Bharti Telecom Limited (2026 INSC 213, 10 March 2026) — Supreme Court upheld selective capital reduction under Section 66, Companies Act 2013, confirming no mandatory valuation report requirement; NCLT scrutiny confined to fairness of price, majority approval, and manifest unreasonableness.
• Court further held NCLAT benches may have a majority of Technical Members without jurisdictional defect, provided at least one Judicial Member sits; parties challenging tribunal composition on this ground will no longer succeed.
• Separately, NCLAT (February 2026) confirmed shareholder class actions are maintainable even for past and concluded transactions in Jindal Poly Films; opens a wider window for minority agitation in listed companies.

Intellectual Property

• CRI Guidelines 2025 (July 2025) clarified examination standards for computer-related inventions, aligning with judicial principles affirmed in Kroll and subsequent Delhi High Court rulings; AI and software patent applications in India now have a clearer prosecution roadmap.
• Supreme Court (Pernod Ricard v. Karanveer Singh Chhabra, 2025) instituted a composite test for interim injunctions in trademark disputes, balancing brand protection against public domain interests in descriptive marks; a structuring consideration for global brand owners operating in India.
• IP Division Rules now active across multiple High Courts (Karnataka, Calcutta, Himachal Pradesh); expedited specialist adjudication is materially improving enforcement predictability for cross-border IP licensors.

Contractual Disputes / Recovery

• Supreme Court (2026) held that contractual clauses cannot create a vacuum of remedies: a party may not be the arbiter of its own breach; Section 28 of the Indian Contract Act voids absolute bars on dispute resolution, even in government contracts.
• Gayatri Balasamy v. ISG Novasoft (2025 INSC 605) — Constitution Bench confirmed courts have limited power to modify (not merely set aside) arbitral awards under Sections 34 and 37 of the Arbitration Act; severable patent illegalities can now be corrected without full remand, reducing delay in commercial award enforcement.
• Disortho S.A.S. v. Meril Life Sciences (2025) — Supreme Court drew the lex contractus/lex arbitri distinction for distributor agreements with split governing law and arbitral seat clauses; cross-border distribution agreements with India-governed substantive terms but foreign-seat arbitration must be re-examined for jurisdictional consistency.

Data Protection / Technology Transactions

• With Phase 1 of DPDP enforcement active, data processing agreements, vendor contracts, and employment documentation across India-based operations require urgent review for DPDP-compliant consent architecture and breach notification obligations.
• Cross-border data transfer restrictions remain absent as of April 2026 (no restricted jurisdictions notified); however, MeitY retains unilateral authority to restrict transfers without advance notice — a structural risk for multinationals relying on India-EU data flows under the new FTA framework.

MARKET TRENDS AND RISK AREAS

Opportunity

• Insurance and fintech sectors present immediate entry opportunities following the 100% FDI liberalisation; foreign insurers and reinsurers can now structure wholly-owned Indian subsidiaries without joint venture constraints, subject to revised management localisation rules.
• India–EU FTA ratification pipeline creates lead time for supply-chain restructuring and IP registration strategy in target export sectors (IT/ITeS, pharmaceuticals, textiles, marine); companies with EU and India operations should begin tariff-position mapping now.

Risk

• DPDP non-compliance risk is live: the DPBI is operational, penalties of up to INR 250 crore apply, and legacy data obligations are already crystallised; companies that have not commenced data governance remediation are in immediate exposure.
• SEBI and CCI enforcement activity is intensifying: SEBI suspended a registered investment advisor and issued a 30-day client bar on Motisons Shares in Q1 2026; CCI scrutiny of M&A combinations requiring pre-clearance under IBC-linked transactions continues to create timeline uncertainty.

Client Exposure

• Foreign-invested Indian entities with employee data, customer data, or B2B vendor data must complete data-mapping, consent redesign, and DPO appointment frameworks before May 2027 — but the compliance window is narrower in practice given DPBI’s active status from November 2025.
• Distribution agreements with India-governed substantive terms and foreign-seat arbitration clauses require immediate audit following Disortho; misaligned governing law / arbitral seat combinations may strand parties between Indian courts and foreign arbitral institutions with no referral jurisdiction.

CROSS-BORDER CONSIDERATIONS

FDI

• Insurance (100% automatic route) and legacy DPIIT bonus-share clarification are the two highest-impact FDI developments for inbound investors in Q1 2026; SWAGAT-FI eligibility for sovereign investors should be assessed ahead of its June 2026 go-live.
• FEMA ECB First Amendment Regulations 2026 expand borrower eligibility and reprice benchmarks; foreign debt instrument structuring for Indian operating companies requires updated legal opinions.

Outbound Activity

• No material change to outbound FEMA/ODI thresholds in Q1 2026; Indian outward FDI to the EU (approximately USD 40 billion stock) will be governed by the new FTA’s investment protection chapter once in force.

Dispute Resolution

• India’s pro-arbitration trajectory is consolidating: limited award modification power (Gayatri Balasamy), rejection of unilateral remedies bars (2026 Supreme Court ruling), and tribunal impleadment doctrine (ASF Buildtech) collectively make India a more reliable arbitration seat for commercial disputes.
• Cross-border contract drafting implication: include explicit lex arbitri designation; split governing law / arbitral seat clauses in distributor and technology agreements carry post-Disortho enforcement risk.

Treaty / Agreement Developments

• India–EU FTA concluded January 2026; provisional text published February 2026; EU ratification expected H1 2027; IP chapter and dispute settlement mechanism are the primary points of counsel attention for cross-border IP and investment structures.
• India–UK CETA signed July 2025; debated in UK House of Commons February 2026; India–Canada CEPA negotiations formally launched March 2026 with a USD 50 billion bilateral trade target by 2030.

OUTLOOK (NEXT 6–12 MONTHS)

• SEBI SWAGAT-FI operationalises 1 June 2026: sovereign, government-linked, and large retail fund investors should complete eligibility reviews and onboarding documentation by May 2026.
• DPDP Phase 2 (November 2026): Consent Manager registration framework activates; organisations with digital platforms serving Indian data principals must have consent architecture operational before this date.
• India–EU FTA final legal scrub and formal signing is expected in H2 2026; IP chapter commitments and data flow provisions will require counsel review for technology and pharma clients with EU-India exposure.
• India–Canada CEPA negotiations are in early rounds; IP (pharmaceutical data protection, patented medicines) and digital trade (cross-border data flows, localisation) are the contested chapters to watch.
• Minority shareholder activism is rising: the Jindal Poly class action confirmation and Pannalal Bhansali guidance will generate a new generation of Section 241–242 and Section 66 proceedings in closely held companies and subsidiaries of foreign groups.
• Direction of travel: India’s legal environment is liberalising on inbound investment and trade access while simultaneously tightening on data governance, beneficial ownership transparency, and enforcement of arbitral awards — a dual-track posture that favours well-structured foreign entrants and penalises non-compliant incumbents.